INTEGRATED DELIVERY DEVICE FOR CONTINUOUS GLUCOSE SENSOR

  • US 20120186581A1
  • Filed: 03/30/2012
  • Published: 07/26/2012
  • Est. Priority Date: 02/26/2004
  • Status: Active Grant
First Claim
Patent Images

1. An integrated system for monitoring and treating diabetes, the system comprising:

  • a glucose sensor, wherein the glucose sensor substantially continuously measures glucose in a host for a period exceeding one hour, and outputs a data stream, including one or more sensor data points;

    a receiver operably connected to the glucose sensor, wherein the receiver is configured to receive the data stream; and

    a medicament delivery device, wherein the delivery device is physically detachably connectable to the receiver, wherein at least one of the receiver and the medicament delivery device comprises programming that automatically detects impending clinical risk and calculates a therapy recommendation responsive to the impending clinical risk, and wherein the at least one of the receiver and the medicament delivery device further comprises programming that requires the at least one of the receiver and the medicament delivery device to be at least one of validated and confirmed by a user interaction in response to a prompt on a user interface of at least one of the receiver and the medicament delivery device for administration of the therapy recommendation.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×